Interius BioTherapeutics’ US$76 Million Series A financing.

Sidley Austin LLP advised Interius BioTherapeutics on the deal.Interius BioTherapeutics, a preclinical stage gene therapy company developing a paradigm-shifting platform for in vivo cell-specific gene delivery,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now